RPG Life Sciences to launch GLP-1 drug in October after ₹215 crore API acquisitions
The GLP-1 push comes as RPG Life Sciences is also rapidly expanding its API business.
Attribution
This digest is published with acknowledgment to Business Today. For the complete analysis, headnotes, and citations, please refer to the source.
Read on Business Today
